1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Guangzhou Hexin Instrument Co., Ltd. Class A

Guangzhou Hexin Instrument Co., Ltd. Class A

SSSE:688622
107.00
CNY
-0.65
(-0.60%)
9.15BMarket Cap
Oct 30Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.73
1.49
1.73
1.74
2.37
4.21
5.93
8.15
3.98
5.22
2.91
1.42
- -
Basic EPS, GAAP
-0.2
0.21
0.3
0.29
0.38
0.89
1.32
1.38
-0.9
-1.37
-0.66
-1.35
- -
Free Cash Flow per Basic Share
0.01
0.5
0.24
-0.32
-0.12
0.58
-0.09
-2.06
-2.31
-2.08
-1.12
-0.35
- -
Dividend per Share
- -
- -
0.01
- -
0.02
0.04
0.07
0.11
0.25
0.16
0.16
0.14
0.11
Book Value per Share
0.86
1.23
1.54
2.11
2.49
3.4
4.77
8.64
7.58
6.22
5.49
4.31
4.03
Tangible Book Value per Share
0.86
1.23
1.52
2.09
2.33
3.23
4.53
7.88
6.76
5.38
4.68
3.55
3.27
Basic Weighted Avg Shares
52
48
53
53
53
52
53
57
70
70
70
70
70
Sales/Revenue/Turnover
38
71
92
93
125
220
312
464
280
366
203
99
- -
Operating Margin (%)
-63.31
-1.18
-2.34
20.94
20.19
25.9
28.88
18.93
-24.76
-21.88
-17.59
-33.24
- -
Depreciation Expense
2
2
2
3
3
5
8
17
26
28
27
24
- -
Net Income, GAAP
-10
10
16
15
20
46
69
79
-63
-96
-46
-95
- -
Effective Tax Rate (%)
- -
17.76
6.63
11.76
15.15
16.39
19.25
15.79
- -
- -
- -
- -
- -
Profit Margin (%)
-26.71
14.08
17.37
16.67
16.06
21.14
22.24
16.93
-22.6
-26.25
-22.71
-95.38
- -
Working Capital
64
81
98
94
102
110
161
396
232
59
40
29
100
LT Debt
- -
- -
- -
- -
- -
- -
31
35
54
105
163
186
270
Total Equity
45
65
81
111
130
176
247
593
511
418
362
280
259
Return on Invested Capital (%)
- -
-2.51
-2.62
15.42
13.35
23.82
22.66
13.1
- -
- -
- -
- -
- -
Return on Capital (%)
- -
16.98
21.21
15.24
15.44
26.07
26.9
17.33
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
18.21
21.93
16.12
16.61
30.07
32.37
18.36
-11.15
-19.9
-11.22
-27.56
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
94
58
75
LT Borrowings
186
233
270
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
70
70
70
Market Capitalization
7,126
6,224
9,146

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
218
200
241
Cash, Cash Equivalents & STI
60
44
91
Accounts Receivable, Net
63
63
60
Inventories
74
71
69
Total Current Liabilities
190
129
140
Payables & Accruals
- -
- -
- -
ST Debt
94
58
75
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.72%
14.5%
-22.72%
Free Cash Flow
127.41%
459.5%
-68.48%
Net Income, GAAP
20.57%
-12.35%
106.13%
Sales/Revenue/Turnover
12.72%
-11.19%
-50.92%
Total Cash Common Dividend
79.77%
41.76%
-12.46%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
47
57
46
53
203
2025
32
21
- -
29
99
2026
19
16
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.21
-0.1
- -
-0.34
-0.66
2025
-0.1
-0.15
- -
-0.83
-1.35
2026
-0.11
-0.17
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.04
0.04
0.04
0.16
2025
0.03
0.04
- -
0.04
0.14
2026
0.03
0.04
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Zhen Zhou
Full Time Employees
199
Sector
Health technology
Industry
Medical specialties
Address
No. 16 Xinrui Road Guangzhou GD China 510535
IPO Date
Sep 13, 2021
Website
tofms.net
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Guangzhou Hexin Instrument Co., Ltd. is a China-based high-tech enterprise specializing in the research, development, manufacturing, and sales of advanced mass spectrometry instruments. The company’s core product portfolio includes portable digital linear ion trap mass spectrometers, online single particle aerosol mass spectrometers (SPAMS series), environmental online monitoring instruments (VOC1500W, SPIMS series), medical instruments (CMI series), laboratory analytical instruments such as GCMS series and LC-TQ series, and homemade instruments including the TAPI-TOF. Guangzhou Hexin also offers data analysis services, technical operation, and maintenance services. Founded in 2004 and headquartered in Guangzhou, the company operates primarily across China and serves sectors including environmental monitoring, medical diagnostics, pharmaceutical research, and laboratory analysis. In recent developments, Guangzhou Hexin Instrument has pursued strategic expansion through the acquisition of Shanghai Liangxi Technology Co., Ltd., aimed at broadening its technology and product offerings. Additionally, the company has engaged in capital market activities such as issuing shares and raising supporting funds to finance acquisitions and business growth. Operationally, it has faced financial challenges including operating losses and has sought credit lines and guarantees to support liquidity. These moves indicate a strategic emphasis on consolidating technology assets and strengthening its market position in the mass spectrometry and analytical instrument industry.